Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator

Shuhei Kimura, Yuki Morizane, Ryo Matoba, Mio Hosokawa, Yusuke Shiode, Masayuki Hirano, Shinichiro Doi, Shinji Toshima, Kosuke Takahashi, Mika Hosogi, Atsushi Fujiwara, Fumio Shiraga

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: To investigate the effectiveness of displacement of submacular hemorrhage (SMH) caused by polypoidal choroidal vasculopathy (PCV) by assessing retinal sensitivity using microperimetry. Methods: We retrospectively reviewed the medical records of 11 consecutive PCV patients with SMH. All patients underwent vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-air exchange, followed by antivascular endothelial growth factor therapy using a pro re nata regimen. The retinal sensitivity was measured by use of microperimetry before and after surgery. Results: The mean (SD) age of the patients was 74.1 ± 9.4 years. The mean SMH diameter was 6.8 ± 5.2 disc diameters. The best-corrected visual acuity (BCVA), mean retinal sensitivity, and mean number of measure points with a sensitivity ≥10 dB before the surgery were 0.94 ± 0.49, 4.2 ± 4.5 dB, and 15.6 ± 15.1 points, respectively. These had significantly improved 6 months after surgery (0.39 ± 0.37, 15.6 ± 7.3 dB, and 50.9 ± 22.2 points, respectively; P < 0.05 for all outcome measures). The mean number of measure points with an absolute scotoma before surgery had decreased significantly 6 months after surgery (from 40.5 ± 15.0 to 9.4 ± 16.0 points; P < 0.001). Conclusions: Displacement of SMH effectively improves retinal sensitivity as well as BCVA.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalJapanese Journal of Ophthalmology
DOIs
Publication statusAccepted/In press - Aug 23 2017

Fingerprint

Tissue Plasminogen Activator
Hemorrhage
Safety
Visual Acuity
Endothelial Growth Factors
Scotoma
Vitrectomy
Medical Records
Air
Outcome Assessment (Health Care)
Injections

Keywords

  • Microperimetry
  • Polypoidal choroidal vasculopathy
  • Submacular hemorrhage
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{6fe0b7ca81cf4972a15c42be0c648464,
title = "Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator",
abstract = "Purpose: To investigate the effectiveness of displacement of submacular hemorrhage (SMH) caused by polypoidal choroidal vasculopathy (PCV) by assessing retinal sensitivity using microperimetry. Methods: We retrospectively reviewed the medical records of 11 consecutive PCV patients with SMH. All patients underwent vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-air exchange, followed by antivascular endothelial growth factor therapy using a pro re nata regimen. The retinal sensitivity was measured by use of microperimetry before and after surgery. Results: The mean (SD) age of the patients was 74.1 ± 9.4 years. The mean SMH diameter was 6.8 ± 5.2 disc diameters. The best-corrected visual acuity (BCVA), mean retinal sensitivity, and mean number of measure points with a sensitivity ≥10 dB before the surgery were 0.94 ± 0.49, 4.2 ± 4.5 dB, and 15.6 ± 15.1 points, respectively. These had significantly improved 6 months after surgery (0.39 ± 0.37, 15.6 ± 7.3 dB, and 50.9 ± 22.2 points, respectively; P < 0.05 for all outcome measures). The mean number of measure points with an absolute scotoma before surgery had decreased significantly 6 months after surgery (from 40.5 ± 15.0 to 9.4 ± 16.0 points; P < 0.001). Conclusions: Displacement of SMH effectively improves retinal sensitivity as well as BCVA.",
keywords = "Microperimetry, Polypoidal choroidal vasculopathy, Submacular hemorrhage, Tissue plasminogen activator",
author = "Shuhei Kimura and Yuki Morizane and Ryo Matoba and Mio Hosokawa and Yusuke Shiode and Masayuki Hirano and Shinichiro Doi and Shinji Toshima and Kosuke Takahashi and Mika Hosogi and Atsushi Fujiwara and Fumio Shiraga",
year = "2017",
month = "8",
day = "23",
doi = "10.1007/s10384-017-0530-0",
language = "English",
pages = "1--7",
journal = "Japanese Journal of Ophthalmology",
issn = "0021-5155",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy

T2 - effectiveness and safety of subretinal tissue plasminogen activator

AU - Kimura, Shuhei

AU - Morizane, Yuki

AU - Matoba, Ryo

AU - Hosokawa, Mio

AU - Shiode, Yusuke

AU - Hirano, Masayuki

AU - Doi, Shinichiro

AU - Toshima, Shinji

AU - Takahashi, Kosuke

AU - Hosogi, Mika

AU - Fujiwara, Atsushi

AU - Shiraga, Fumio

PY - 2017/8/23

Y1 - 2017/8/23

N2 - Purpose: To investigate the effectiveness of displacement of submacular hemorrhage (SMH) caused by polypoidal choroidal vasculopathy (PCV) by assessing retinal sensitivity using microperimetry. Methods: We retrospectively reviewed the medical records of 11 consecutive PCV patients with SMH. All patients underwent vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-air exchange, followed by antivascular endothelial growth factor therapy using a pro re nata regimen. The retinal sensitivity was measured by use of microperimetry before and after surgery. Results: The mean (SD) age of the patients was 74.1 ± 9.4 years. The mean SMH diameter was 6.8 ± 5.2 disc diameters. The best-corrected visual acuity (BCVA), mean retinal sensitivity, and mean number of measure points with a sensitivity ≥10 dB before the surgery were 0.94 ± 0.49, 4.2 ± 4.5 dB, and 15.6 ± 15.1 points, respectively. These had significantly improved 6 months after surgery (0.39 ± 0.37, 15.6 ± 7.3 dB, and 50.9 ± 22.2 points, respectively; P < 0.05 for all outcome measures). The mean number of measure points with an absolute scotoma before surgery had decreased significantly 6 months after surgery (from 40.5 ± 15.0 to 9.4 ± 16.0 points; P < 0.001). Conclusions: Displacement of SMH effectively improves retinal sensitivity as well as BCVA.

AB - Purpose: To investigate the effectiveness of displacement of submacular hemorrhage (SMH) caused by polypoidal choroidal vasculopathy (PCV) by assessing retinal sensitivity using microperimetry. Methods: We retrospectively reviewed the medical records of 11 consecutive PCV patients with SMH. All patients underwent vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-air exchange, followed by antivascular endothelial growth factor therapy using a pro re nata regimen. The retinal sensitivity was measured by use of microperimetry before and after surgery. Results: The mean (SD) age of the patients was 74.1 ± 9.4 years. The mean SMH diameter was 6.8 ± 5.2 disc diameters. The best-corrected visual acuity (BCVA), mean retinal sensitivity, and mean number of measure points with a sensitivity ≥10 dB before the surgery were 0.94 ± 0.49, 4.2 ± 4.5 dB, and 15.6 ± 15.1 points, respectively. These had significantly improved 6 months after surgery (0.39 ± 0.37, 15.6 ± 7.3 dB, and 50.9 ± 22.2 points, respectively; P < 0.05 for all outcome measures). The mean number of measure points with an absolute scotoma before surgery had decreased significantly 6 months after surgery (from 40.5 ± 15.0 to 9.4 ± 16.0 points; P < 0.001). Conclusions: Displacement of SMH effectively improves retinal sensitivity as well as BCVA.

KW - Microperimetry

KW - Polypoidal choroidal vasculopathy

KW - Submacular hemorrhage

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=85027975501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027975501&partnerID=8YFLogxK

U2 - 10.1007/s10384-017-0530-0

DO - 10.1007/s10384-017-0530-0

M3 - Article

C2 - 28836011

AN - SCOPUS:85027975501

SP - 1

EP - 7

JO - Japanese Journal of Ophthalmology

JF - Japanese Journal of Ophthalmology

SN - 0021-5155

ER -